Contrariwise, the presence in HCC of other proteolytic products of proteoglycans or full-length proteoglycans, such as endostatin and PRG4, is potentially beneficial due to their anti-angiogenic and drug-enhancing abilities. Here, COL18A1 is linked to hepatocellular carcinoma.